{"id":"NCT00320710","sponsor":"Novartis Pharmaceuticals","briefTitle":"Continued Efficacy and Safety of Zoledronic Acid (q 4 Wks vs. q 12 Wks) in the 2nd Year of Treatment in Patients With Bone Metastases From Breast Cancer","officialTitle":"A Prospective, Randomized, Double-blind, Stratified, Multi-center, 2-arm Trial of the Continued Efficacy and Safety of Zoledronic Acid (Every 4 Weeks vs. Every 12 Weeks) in in the 2nd Year of Treatment in Patients With Documented Bone Metastases From Breast Cancer","status":"COMPLETED","phase":"PHASE3","dates":{"start":"2006-02","primaryCompletion":"2013-07","completion":"2013-07","firstPosted":"2006-05-03","resultsPosted":"2014-08-04","lastUpdate":"2014-08-22"},"enrollment":416,"design":{"allocation":"RANDOMIZED","model":"PARALLEL","masking":"DOUBLE","primaryPurpose":"TREATMENT"},"conditions":["Breast Cancer"],"interventions":[{"type":"DRUG","name":"Zoledronic acid","otherNames":["Zoledronate","ZOL446","Zometa"]},{"type":"DRUG","name":"Placebo","otherNames":[]}],"arms":[{"label":"Zoledronic acid every (q) 4 weeks","type":"EXPERIMENTAL"},{"label":"Zoledronic acid q 12 weeks","type":"EXPERIMENTAL"},{"label":"Placebo / zoledronic acid","type":"EXPERIMENTAL"}],"summary":"Clinical trial in breast cancer patients with bone metastases pretreated for approximately 1 year with a standard zoledronic acid regimen. Looking at the continued effectiveness and safety of giving zoledronic acid every 4 weeks versus every 12 weeks given over 1 year. This study is prospective, double-blind, stratified, multi-center, and two-arm.","primaryOutcome":{"measure":"Proportion of Patients Who Experienced at Least One Skeletal Related Event (SRE)","timeFrame":"52 weeks","effectByArm":[{"arm":"Zoledronic Acid Every (q) 4 Weeks","deltaMin":22,"sd":null},{"arm":"Zoledronic Acid q 12 Weeks","deltaMin":23.2,"sd":null}],"pValues":[]},"eligibility":{"minAge":"18 Years","sex":"FEMALE","healthyVolunteers":false,"inclusionCount":null,"exclusionCount":null},"locations":{"siteCount":92,"countries":["United States"]},"refs":{"pmids":["28125763"],"seeAlso":["http://www.novartisclinicaltrials.com/webapp/etrials/searchTrial.do?trialID=513"]},"adverseEventsSummary":{"seriousAny":{"events":50,"n":198},"commonTop":["Fatigue","Arthralgia","Nausea","Pain in extremity","Back pain"]}}